Ticker: CBPO, Company: China Biologic Products, Inc., Type: 10-Q, Date: 2013-08-06, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CBPO/20130806/10-Q/1/000.htm SEC Original: v350718_10q.htm

---

---

Webplus: CBPO/20130806/10-Q/2_EX-3.3/000.htm SEC Original: v350718_ex3-3.htm
CHINA BIOLOGIC PRODUCTS, INC. 2008 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT Unless otherwise defined herein, the terms defined in the China Biologic Products, Inc. 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Award Agreement (the “Award Agreement”). I. NOTICE OF RESTRICTED STOCK GRANT You have been granted the right to receive

---

---

Webplus: CBPO/20130806/10-Q/3_EX-31.1/000.htm SEC Original: v350718_ex31-1.htm
CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such

---

---

Webplus: CBPO/20130806/10-Q/4_EX-31.2/000.htm SEC Original: v350718_ex31-2.htm
CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CBPO/20130806/10-Q/5_EX-32.1/000.htm SEC Original: v350718_ex32-1.htm
OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer

---

---

Webplus: CBPO/20130806/10-Q/6_EX-32.2/000.htm SEC Original: v350718_ex32-2.htm
OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 10-Q, Date: 2013-08-06, XBRL Interactive FinancialsCIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125